Answer
QT prolongation and other ECG changes have been reported. Risk assessment is particularly important with heart disease, electrolyte abnormalities, cardiotoxic treatment or other QT-prolonging medicines.
Sources for this answer
- Granisetron 1 mg/ml concentrate for solution for injection or infusion — Current selected SmPCemc · Summary of Product Characteristics
- Kytril 2 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics